₹ 246.37
0.17 (0.07%)
P
Piramal Pharma
₹ 246.37
Piramal Pharma EPS Summary (consolidated)
The latest quarterly EPS of Piramal Pharma as of Q2 Sep 2026 stands at ₹0.04. This is a 107.69% growth quarter on quarter and 105.33% growth same quarter last year. The forecasted EPS for Q2 Sep 2026 was ₹-0.26. It beat the estimate by ₹0.30. For the FY2026 the EPS of Piramal Pharma stands at ₹-2.46. This is a 456.52% fall compared with FY2025.
Piramal Pharma EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

